Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies
Open Access
- 9 February 2009
- journal article
- Published by Springer Nature in Child and Adolescent Psychiatry and Mental Health
- Vol. 3 (1) , 5
Abstract
The impact of once daily atomoxetine treatment on symptoms in children and adolescents with ADHD may vary over the day. In order to capture such variations, two studies were undertaken in children and adolescents with ADHD using two instruments that capture morning and evening behavior and ADHD-related difficulties over the day. This secondary measure analysis builds on two primary analyses that were conducted separately for children and adolescents and also published separately.Keywords
This publication has 38 references indexed in Scilit:
- Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)Child and Adolescent Psychiatry and Mental Health, 2008
- Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: Reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the dayChild and Adolescent Psychiatry and Mental Health, 2008
- A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorderChild and Adolescent Psychiatry and Mental Health, 2007
- Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European studyEuropean Child & Adolescent Psychiatry, 2006
- Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatmentEuropean Child & Adolescent Psychiatry, 2006
- Atomoxetine in the Management of Children with ADHD: Effects on Quality of Life and School FunctioningClinical Pediatrics, 2006
- Long-acting medications for the hyperkinetic disordersEuropean Child & Adolescent Psychiatry, 2006
- Non?stimulant medications in the treatment of ADHDEuropean Child & Adolescent Psychiatry, 2004
- Comparative efficacy of once?a?day extended?release methylphenidate, two?times?daily immediate?release methylphenidate, and placebo in a laboratory school settingEuropean Child & Adolescent Psychiatry, 2004
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002